Article info

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Authors

  1. Correspondence to Professor Atul Deodhar, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA; deodhara{at}ohsu.edu
View Full Text

Citation

Deodhar A, Sliwinska-Stanczyk P, Xu H, et al
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Publication history

  • Received November 26, 2020
  • Revised March 11, 2021
  • Accepted March 16, 2021
  • First published April 27, 2021.
Online issue publication 
July 13, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.